| Name | carnitinamide chloride |
|---|---|
| Synonyms |
3- CBOXY-N,N,N-TRIMETHYL-2-PROPEN-1-AMINIUM CHLORIDE
3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium chloride 3-Hydroxy-4-(trimethylammonio)butanoate hydrochloride Vitamin BT Hydrochloride CNITINE CHLORIDE 3-Hydroxy-4-(trimethylammonio)butyrate Hydrochloride BICNESINE BICNESINE HCL (2,4-dihydroxy-4-keto-butyl)-trimethyl-ammonium chloride MFCD00011904 3-hydroxy-4-trimethylazaniumyl-butanoate hydrochloride TIMTEC-BB SBB003568 DL-γ-Amino-β-hydroxybutyric acid triMethylbetaine hydrochloride 3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium, inner salt, hydrochloride (1:1) (+/-)-CNITINE CHLORIDE DL-Cnitine hydroch (+-)-cnitinehydrochloride DL-γ-TriMethyl-β-hydroxybutyrobetaine hydrochloride QV1YQ1K1&1&1 &&Anhydro HCl DL-Carnitine Hydrochloride Monocamin 3-cboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium chloride 1-Propanaminium, 3-cboxy-2-hydroxy-N,N,N-trimethyl-, chloride (9CI) 3-cboxy-2-hydroxy-n,n,n-trimethyl-,chloride,(+-)-1-propanaminiu B-HYDROXY-GAMMA-TRIMETHYLAMINOBUTYRIC ACID Bicnesine-d9 VITAMIN BT HYDROCHLORIDE 1-Propanaminium, 3-carboxy-2-hydroxy-N,N,N-trimethyl-, chloride (1:1) DL-CNITINE CHLORIDE 3-HYDROXY-4-(TRIMETHYLAMMONIO)BUTYRATE HYDROCHLORIDE 3-cboxy-2-hydroxy-n,n,n-trimethyl-,chloride,(+/-)-1-propanaminiu DL-CNITINE HCL Flatistine Carnitine chloride DL-CNITINE HCL (JPC97) LEVOCNITINE Aplegin-d9 β-hydroxy-γ-(trimethylammonio)butyrate hydrochloride DL-Cnitine hydrochloride, R Ammonium, (3-cboxy-2-hydroxypropyl)trimethyl-, chloride, (+-)- (8CI) (3-Cboxy-2-hydroxypropyl)(trimethyl-d9)ammonium Chloride β-Hydroxy-γ-(trimethylammonio)butyrate hydrochloride, (±)-Cnitine chloride, DL-Cnitine hydrochloride DL-Cnitine Hydrochloride 〔Vitamin BT〕 DL-Cnitine hydrochloride(CH3)+3NCH2CH(OH)CH2COO·HCl 1-PROPANAMINIUM-3-CBOXY-2-HYDROXY-N,N,N-TRIMETHYL HYDROXIDE HYDROCHLORIDE 1-Propanaminium, 3-cboxy-2-hydroxy-N,N,N-trimethyl-, chloride L(-)-CNITINE HCL N-(3-cboxy-2-hydroxypropyl)-N,N,N-trimethylammonium chloride EINECS 207-309-1 L-CNITINE HCL UNII:F64264D63N (±)-Carnitine (chloride) 3-Cboxy-2-hydroxy-N,N,N-(trimethyl-d9)-1-propanaminium Chloride carnitine hydrochloride (3-cboxy-2-hydroxypropyl)trimethyl-,chloride,(+-)-ammoniu BETA-HYDROXY-GAMMA-TRIMETHYLAMINOBUTYRIC ACID HYDROCHLORIDE DL-Cnitine hydrochloride (2,4-dihydroxy-4-oxo-butyl)-trimethyl-ammonium chloride L-CNITINE MONOHYDROCHLORIDE L-CNITINE HYDROCHLOIRDE (BOVINE) dl-bicnesine hydrochloride LABOTEST-BB LT00077075 3-hydroxy-4-trimethylazaniumylbutanoate hydrochloride CNITINE CHLORIDE, DL TIMTEC-BB SBB003557 (2,4-dihydroxy-4-oxobutyl)-trimethylammonium chloride (2,4-Dihydroxy-4-oxobutyl)-trimethylazanium chloride (2,4-dihydroxy-4-oxo-butyl)-trimeth 3-Carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium chloride |
| Description | (±)-Carnitine chloride exists in two isomers, known as D and L. L-carnitine plays an essential role in the β-oxidation of fatty acids and also shows antioxidant, and anti-inflammatory activities. |
|---|---|
| Related Catalog | |
| In Vitro | The main role of L-carnitine is to shuttle long-chain fatty acids across the inner mitochondrial membrane. After L-carnitine and acyl-CoA become acyl-carnitine by activation of carnitine palmitoyl transferase (CPT)-I, the transported acyl-carnitine is changed into acyl-CoA by CPT-II in the mitochondria matrix. Palmitoyl-CoA-induced mitochondrial respiration is increased by L-carnitine treatment, and then is accelerated by the presence of ADP. This acceleration is induced by treatment with L-carnitine in a concentration-dependent manner, and is saturated at 5 mM L-carnitine[1]. Pretreatment with L-carnitine augments Nrf2 nuclear translocation, DNA binding activity and heme oxygenase-1 (HO-1) expression in H2O2-treated HL7702 cells. L-carnitine protects HL7702 cells against H2O2-induced cell damage through Akt-mediated activation of Nrf2 signaling pathway[2]. |
| In Vivo | L-carnitine is found to down-regulate the ubiquitin proteasome pathway and increase IGF-1 concentrations in animal models. L-carnitine administration for 2 weeks of hindlimb suspension alleviates the decrease in weight and fiber size in the soleus muscle. In addition, L-carnitine suppresses atrogin-1 mRNA expression, which has been reported to play a pivotal role in muscle atrophy[3]. Simultaneous treatment with L-carnitine attenuates the renal fibrosis (which correlated with a reduction of plasma TGF-β1 levels) and the pro-oxidative and proinflammatory status reported in L-NAME groups, with a concomitant increase in the expression of PPAR-γ[4]. |
| Kinase Assay | Mitochondria (0.6 mg protein/mL) are incubated in 2.5 mM Hepes (pH7.4) containing 225 mM mannitol, 75 mM sucrose and 100 μM ethylene glycol tetraacetic acid (EGTA) with or without 5 mM L-carnitine at 25°C. To measure oxygen uptake, 10 min after inorganic phosphate (Pi) 4 mM are added, the mitochondria are treated with palmitoyl-CoA (50 μM) and then ADP is added (200 μM). Oligomycin (5 μM) and rotenone (10 μM) are added 3-4 min after the ADP treatment. HPG (0-10 mM), which can specifically inhibit carnitine palmitoyl transferase (CPT)-I activity in the mitochondria, is added in the Hepes medium before incubation of the mitochondria[1]. |
| Animal Admin | Rats: After 1 week of acclimatization, rats are randomly assigned to a hindlimb suspension group, hindlimb suspension with L-carnitine administration group, and a pair-fed group. The L-carnitine group are administered a 1250 mg L-carnitine/kg dissolved in distilled water orally using a sonde. The body weight is measured every morning at 09:00 and L-carnitine solution is ingested every morning at 10:00. The experiment is conducted for 14 days[3]. |
| References |
| Melting Point | 190-205ºC |
|---|---|
| Molecular Formula | C7H16ClNO3 |
| Molecular Weight | 197.660 |
| Exact Mass | 197.081863 |
| PSA | 57.53000 |
| Water Solubility | SOLUBLE |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
| Personal Protective Equipment | dust mask type N95 (US);Eyeshields;Gloves |
|---|---|
| Hazard Codes | Xi:Irritant |
| Risk Phrases | R36/37/38 |
| Safety Phrases | S26-S37/39 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | BP2979140 |
| HS Code | 2923900090 |
|
~%
461-05-2 |
| Literature: Lonza Ltd. Patent: US3969406 A1, 1976 ; |
| Precursor 2 | |
|---|---|
| DownStream 7 | |
| HS Code | 2923900090 |
|---|---|
| Summary | 2923900090 other quaternary ammonium salts and hydroxides。Supervision conditions:None。VAT:17.0%。Tax rebate rate:9.0%。MFN tariff:6.5%。General tariff:30.0% |